Private Label Glycolic Acid Eye Cream Manufacturer Low MOQ

What are the most common issues with private label glycolic acid eye cream and how do I avoid them?

By Blake Mereby · Last reviewed October 4, 2026

The five most frequent issues that indie brands encounter when launching a private label glycolic acid eye cream are: pH instability or creep (pH rises over time, reducing glycolic acid efficacy and risking irritation), emulsion separation or breaking (oil and water phases split, creating an unusable product), glycolic acid degradation or oxidation (concentration drops during storage, weakening the product), inadequate preservation leading to microbial contamination, and over-concentration causing irritation or sensitization complaints. Each is preventable with proper formula design, stability testing, and manufacturer oversight.

pH instability is the most insidious because it often occurs gradually over weeks or months. Glycolic acid is buffered at pH 3.0–4.0 using sodium hydroxide or triethanolamine, but in the presence of air (oxygen), light, and heat, the buffer can drift upward as glycolic acid oxidizes or as the buffer agent reacts with trace metals or impurities in the formula. A product that ships at pH 3.2 may arrive at a distributor's warehouse at pH 3.5 and, after 6 months on a shelf under fluorescent lights, drift to pH 4.2. At pH 4.2 or higher, glycolic acid's penetration and exfoliating efficacy diminish sharply, and user reviews will reflect "didn't notice a difference." To avoid this, ensure the manufacturer uses a stabilized buffer system (often including chelating agents like EDTA to bind trace metals) and packages the cream in opaque, air-tight containers (glass or opaque plastic jars with tight seals, not clear plastic or jars with gaps). Request that the lab run pH testing at baseline, 4 weeks, 8 weeks, and 12 weeks of accelerated stability at 40°C/75% RH; pH should not drift more than ±0.3 units. If it does, ask the manufacturer to reformulate the buffer or switch to a different chelating agent.

Emulsion separation is another top failure mode, particularly in glycolic acid eye creams that combine water-loving hydrating actives (glycerin, hyaluronic acid) with oil-based emollients (dimethicone, squalane). If the emulsifier concentration is too low, or if the ratio of oil to water is out of balance, the emulsion can break during storage or shipping (especially if containers experience temperature swings). Signs include visible oil or water droplets in the jar, a grainy texture, or separation of a liquid layer on top. This is both a cosmetic and a functional failure—an unstable emulsion degrades active ingredients, loses the intended texture, and communicates poor quality. Manufacturers prevent this by selecting robust emulsifiers (ceteth-20, polysorbate 80, or lecithin-based systems) at concentrations of 3–6% and validating emulsion stability under stress conditions (heating-cooling cycles, freeze-thaw cycles, vigorous shaking) in the lab before production. Always ask for emulsion stability testing (not just microbial and pH); a competent manufacturer will provide data showing the emulsion remained homogeneous through 3–5 heating-cooling cycles from 25°C to 40°C and back.

Glycolic acid degradation occurs when the active is exposed to alkaline conditions, high heat, or high light. Glycolic acid is most stable at pH 3.0–4.0; if pH rises above 4.5, glycolic acid begins to degrade (hydrolyze) and loses potency. Conversely, if the formula is stored above 30°C (especially above 40°C) or under direct sunlight, oxidation can degrade glycolic acid over weeks. To mitigate, work with a manufacturer that uses UV-stabilized or opaque packaging, tests storage at controlled temperatures, and includes an antioxidant (vitamin E, ferulic acid, or sodium metabisulfite) to protect glycolic acid from oxidation. Request the manufacturer confirm glycolic acid concentration at baseline and after 12 weeks of accelerated storage; concentration should remain within 95–105% of the stated level. A drop below 95% signals either degradation or measurement error, both of which warrant investigation.

Microbial contamination is a regulatory and safety disaster. Glycolic acid eye creams contain water and hydrating actives, which are susceptible to mold and bacterial growth if the preservative system is inadequate. A product that passes microbial testing at release but then develops mold six months later on a retailer's shelf is a sign that the preservative level was underestimated or that the water activity (aw) was not controlled. Manufacturers must select a preservative system appropriate for the formula's water content and intended shelf life. A typical glycolic acid eye cream with 30–50% water requires a multi-component preservative: phenoxyethanol (0.5–1%) plus sodium benzoate and potassium sorbate (0.5–1% total) or a newer option like Leuconostoc ferment filtrate (0.5–1%). The lab should conduct a challenge test, in which the formula is deliberately inoculated with microbes and the preservative's ability to control microbial growth is measured over time. This is a formal requirement under ISO 11930 and the Cosmetics Regulation. Do not accept a CoA that lists "passes USP <61> microbial limits" (standard microbial plate count) without evidence of a formal challenge test; standard testing only confirms the absence of contamination at release, not the preservative's long-term efficacy.

Over-concentration or irritation complaints arise when the glycolic acid level is too high, the pH is too low, or secondary actives are included at concentrations that heighten irritation. A 12% glycolic acid eye cream, even at pH 3.5, can cause persistent redness, stinging, or sensitization in users with sensitive skin or those who use it more than 2–3 times per week. Many indie brands are tempted to increase glycolic acid concentration to compete on "strength" or efficacy, but this is a liability risk and leads to customer complaints and returns. Stick to 5–10% glycolic acid for an eye cream, and always include clear usage instructions on the label: "Use 2–3 times per week. Do not use daily. Discontinue if irritation occurs." If you include secondary actives like niacinamide, resveratrol, or peptides, confirm with the manufacturer that the combined irritancy has been assessed. Some combinations (e.g., glycolic acid + high-dose retinol + strong essential oils) are too irritating for eye skin and will generate complaints.

The biggest mistake founders make is launching without conducting a formal consumer patch test or sensitivity study. Before sending products to retailers or influencers, recruit 10–20 volunteers from your target demographic, provide them with the product and clear instructions, and ask them to report any irritation, stinging, or unusual reactions over 4 weeks of use at the recommended frequency. A simple survey asking "Did you experience any discomfort or redness?" will surface irritation issues before they become public reviews. Work with the manufacturer to validate that your formula meets the Sensitive Skin/Eye Irritation criteria (typically <1% irritation rate in a 20–50 subject patch test). This step is especially critical for eye products, where safety concerns drive regulatory scrutiny and customer trust.

Ingredients in this answer: Glycolic Acid · Sodium Hydroxide · Triethanolamine · Hyaluronic Acid · Glycerin

Read the full guide on Private Label Glycolic Acid Eye Cream Manufacturer Low MOQ →

More about Private Label Glycolic Acid Eye Cream Manufacturer Low MOQ

Tell us about your product

Tell us your product and quantities. Find vetted contract manufacturers and custom labs on AJ Cosmo Labs, with payments held in escrow. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app